The standard for measuring cannabis effects
Zentrela’s neurotechnology platform is the first scientifically proven test to objectively quantify cannabis psychoactive effects.
Zentrela was founded in 2016 by Israel Gasperin when he combined his fascination with brainwave analysis and his business observation that every facet of the exploding cannabis sector was going to need access to objective product effect data.
Israel was joined by Dr. Dan Bosnyak, a neuroscientist teaching at McMaster University, and together they established the foundations of Zentrela, a neurotechnology pioneer using AI to analyze EEG data in pursuit of the world’s largest database of cannabis psychoactive effects.
Contact Email: [email protected]
Are you hoping to connect with this partner? Fill out our form below and we can reach out to you to find the best way to connect you.